ceritinib and Fanconi-Anemia

ceritinib has been researched along with Fanconi-Anemia* in 1 studies

Other Studies

1 other study(ies) available for ceritinib and Fanconi-Anemia

Article	Year
Clinical response of the novel activating ALK-I1171T mutation in neuroblastoma to the ALK inhibitor ceritinib. Cold Spring Harbor molecular case studies, 2018, Volume: 4, Issue:4 Topics: 3T3 Cells; Adolescent; Anaplastic Lymphoma Kinase; Animals; Brain Neoplasms; Fanconi Anemia; Fanconi Anemia Complementation Group A Protein; Humans; Male; Mice; Mutation, Missense; Neuroblastoma; PC12 Cells; Protein Kinase Inhibitors; Pyrimidines; Rats; Sulfones	2018

Article

Year

Clinical response of the novel activating ALK-I1171T mutation in neuroblastoma to the ALK inhibitor ceritinib.

Cold Spring Harbor molecular case studies, 2018, Volume: 4, Issue:4

Topics: 3T3 Cells; Adolescent; Anaplastic Lymphoma Kinase; Animals; Brain Neoplasms; Fanconi Anemia; Fanconi Anemia Complementation Group A Protein; Humans; Male; Mice; Mutation, Missense; Neuroblastoma; PC12 Cells; Protein Kinase Inhibitors; Pyrimidines; Rats; Sulfones

2018